Limbic-predominant age-related transactive response DNA-binding protein 43 (TDP-43) encephalopathy neuropathological change

1. Hormone replacement therapy lowers the risk of limbic-predominant age-related transactive response DNA-binding protein 43 (TDP-43) encephalopathy neuropathological change in humans (OR = 0.70, 95% CI = 0.50 to 0.98, p = 0.03).

   Humanswithin 5 years before or after menopausefemales

   Hormone replacement therapy and its association with LATE-NC in older adults

   Alzheimer's & dementia : the journal of the Alzheimer's Association·1 Aug 2026

More on Hormone replacement therapy